Company founded
1937
Number of employees
525
Annual revenue
$52000000
Nephron Pharmaceuticals Corporation has manufactured generic respiratory therapy solutions since 1937. Our company proudly offers Racepinephrine Inhalation Solution 2.25%, Albuterol Sulfate Inhalation Solution 0.5% (2.5mg/0.5mL), 0.083% (2.5mg/3mL) and 0.042% (1.25mg/3mL), Ipratropium Bromide Inhalation Solution 0.02%, and Sodium Chloride Inhalation Solution USP, 0.9%. Located in Orlando, Florida, Nephron manufactures these solutions in accordance with Good Manufacturing Practices.